我們已在上線！進一步了解

Oscar Health

OSCR

市值 US$98.4億

31.89 USD

-1.58

4.72%

收盤時已更新 10月16日下午4:00 EDT

盤前交易

盤後交易

31.81

-0.08

0.25%

1天

-4.72%

5天

-5.37%

1個月

-1.39%

3個月

10.5%

6個月

104.03%

今年迄今

113.03%

1年

51.64%

5年

115.18%

10年

-8.36%

關於： Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.

員工： 2,305

醫療保健健康保險計畫

新聞

正面

中性

負面

市場情緒 3個月

正面 74%

中性 22.1%

負面 3.9%

Zacks Investment Research

Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy?

Oscar Health outshines Molina Healthcare with surging membership, stronger earnings growth prospects, a more attractive valuation and robust stock gains.

Oscar Health vs. Molina: Which Healthcare Stock Is a Better Buy?

Zacks Investment Research

Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why

The latest trading day saw Oscar Health, Inc. (OSCR) settling at $33.47, representing a -2.48% change from its previous close.

Oscar Health, Inc. (OSCR) Stock Sinks As Market Gains: Here's Why

Zacks Investment Research

3 Top Ranked Stocks Gaining Despite Market Turmoil

Heico, Cinemark and Oscar Health are three stocks showing relative strength against the broader market.

3 Top Ranked Stocks Gaining Despite Market Turmoil

Oscar Health: 7X The Revenue Since Its IPO, And A Rerating Due In 2027

Oscar Health trades ~13% below its 2021 IPO price, even though management expects 2026 revenue at ~7X its 2021 level. The expiry of enhanced ACA subsidies has always been the main bear case, and it already happened: OSCR grew members ~60% while the ACA market shrank ~13%. For 2027, I see competitor exits, double digit price increases, and consensus EPS below management's own targets as the setup for a rerate.

Oscar Health: 7X The Revenue Since Its IPO, And A Rerating Due In 2027

Zacks Investment Research

Best Growth Stocks to Buy for October 15th

WOOF, FIVE, and OSCR it to the Zacks Rank #1 (Strong Buy) growth stocks list on October 13,52026.

Best Growth Stocks to Buy for October 15th

Zacks Investment Research

Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts

In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $34.32, indicating a +1.57% shift from the previous trading day.

Oscar Health, Inc. (OSCR) Rises As Market Takes a Dip: Key Facts

Zacks Investment Research

Oscar Health, Inc. (OSCR) is a Top-Ranked Momentum Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Oscar Health, Inc. (OSCR) is a Top-Ranked Momentum Stock: Should You Buy?

Zacks Investment Research

Why Fast-paced Mover Oscar Health (OSCR) Is a Great Choice for Value Investors

Oscar Health (OSCR) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Why Fast-paced Mover Oscar Health (OSCR) Is a Great Choice for Value Investors

Zacks Investment Research

Is Oscar Health Stock a Buy as Growth Surges but Valuation Stays Rich?

Oscar Health's surging revenue, membership gains and improving profitability bolster its growth story, but premium valuation and churn risks cloud its outlook.

Is Oscar Health Stock a Buy as Growth Surges but Valuation Stays Rich?

Zacks Investment Research

Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve

Oscar Health raises its 2026 operating earnings outlook to $500M-$700M as pricing gains and tech efficiencies lift margins, despite rising churn and medical costs.

Oscar Health Raises 2026 Operating Earnings Outlook as Margins Improve

查看新聞排名

價格圖表採用Lightweight Charts™實作